Track Indraprastha Medical Corporation Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 7.56 %
Low
325.9
High
363.8
1 Month returns: 14.60 %
Low
293.5
High
363.8
1 Year returns: -32.12 %
Low
293.5
High
544.0
3 Year CAGR: 19.50 %
Low
154.5
High
640.8
5 Year CAGR: 35.48 %
Low
52.0
High
640.8
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Indraprastha Medical Corporation Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Indraprastha Medical Corporation Ltd. Shareholding Pattern
Quarterly breakdown of Indraprastha Medical Corporation Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Indraprastha Medical Corporation Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Indraprastha Medical Corporation Ltd.?
The current share price of Indraprastha Medical Corporation Ltd. is ₹ 361.40 as of 19 Nov 2026.
What is the market capitalisation of Indraprastha Medical Corporation Ltd.?
The market capitalisation of Indraprastha Medical Corporation Ltd. stands at ₹ 3,313.06 Cr.
What is the PE ratio of Indraprastha Medical Corporation Ltd.?
The Price-to-Earnings (PE) ratio of Indraprastha Medical Corporation Ltd. is 17.24 as of the latest trailing twelve months data.
What is the ROE and ROCE of Indraprastha Medical Corporation Ltd.?
Indraprastha Medical Corporation Ltd. has a Return on Equity (ROE) of 26.09% and a Return on Capital Employed (ROCE) of 31.75% as per the latest financial reports.
What is the 52-week high and low of Indraprastha Medical Corporation Ltd.?
The 52-week high of Indraprastha Medical Corporation Ltd. is - and the 52-week low is -.
What is the dividend yield of Indraprastha Medical Corporation Ltd.?
The dividend yield of Indraprastha Medical Corporation Ltd. is 1.11% based on the current market price.
What is the FII and DII holding in Indraprastha Medical Corporation Ltd.?
Foreign Institutional Investors (FII) hold 2.39%, Domestic Institutional Investors (DII) hold 0.91% and retail/public investors hold 37.37% of Indraprastha Medical Corporation Ltd. shares.
What sector does Indraprastha Medical Corporation Ltd. belong to?
Indraprastha Medical Corporation Ltd. operates in the Healthcare sector.
What is the beta of Indraprastha Medical Corporation Ltd.?
The beta of Indraprastha Medical Corporation Ltd. is 1.16, indicating its price volatility relative to the broader market. Over the past 1 year, Indraprastha Medical Corporation Ltd. has delivered an absolute return of -33.92%.
What is the RSI of Indraprastha Medical Corporation Ltd.?
The 14-day Relative Strength Index (RSI) of Indraprastha Medical Corporation Ltd. is 65.68, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Mar 2020
Jun 2020
Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Promoter
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
51.00
Indian Promoter
49.39
49.39
49.39
49.39
51.00
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
49.39
Foreign Promoter
1.61
1.61
1.61
1.61
-
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
1.61
Institutions
0.13
0.16
0.02
0.02
0.02
0.02
0.05
0.20
0.16
0.11
0.17
0.77
0.27
0.37
7.51
7.32
5.99
4.85
5.84
6.07
6.50
6.28
5.92
3.54
3.32
3.35
4.16
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
0.00
-
-
-
-
-
-
2.61
2.66
2.65
2.62
2.62
2.62
-
0.01
0.01
0.91
FI/Bank/Insurance
0.12
0.16
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.00
0.00
0.00
6.71
6.36
4.91
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.03
0.18
0.14
0.09
0.15
0.77
0.27
0.37
0.81
0.95
1.08
1.70
2.64
2.88
2.94
2.73
2.41
2.72
2.43
2.77
2.39
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.53
0.53
0.53
0.94
0.94
0.89
0.82
0.86
0.57
0.86
Non-Institution
48.87
48.84
48.98
48.98
48.98
48.98
48.96
48.80
48.84
48.89
48.83
48.22
48.72
48.62
41.49
41.68
43.01
44.15
43.16
42.93
42.51
42.72
43.08
45.44
45.69
45.65
44.84
Bodies Corporate
13.64
14.64
13.65
14.25
14.78
1.18
12.63
12.94
12.82
12.56
12.68
13.06
13.92
13.99
7.25
7.24
7.81
8.36
7.43
6.66
6.61
6.88
6.96
7.28
7.47
6.76
7.47
Others (incl. Retail)
No. of shareholders
35.23
36,233
34.20
45,157
35.33
47,511
34.73
47,788
34.20
44,590
47.80
59,068
36.33
57,731
35.86
56,988
36.02
56,296
36.33
55,043
36.15
55,040
35.16
52,468
34.80
49,539
34.63
48,342
34.24
47,543
34.44
51,108
35.20
53,797
35.79
54,730
35.73
64,266
36.27
69,282
35.90
70,078
35.84
69,798
36.12
70,514
38.16
70,790
38.22
72,529
38.89
74,605
37.37
77,212
Company Profile
Overview of Indraprastha Medical Corporation Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. It has approximately 52 specialties under one roof with the major specialties being anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics & gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, neurosciences, ophthalmology, orthopedics, otolaryngology (ENT), pediatrics, pediatric surgery, psychiatry and clinical psychology, rheumatology, spine surgery, urology and andrology and vascular and endovascular surgery.
Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. Indraprastha Apollo Hospitals is a multi-specialty tert...
Key personnel
Mr. C. P. Tyagi
Chief Financial Officer
Mr. Priya Ranjan
Company Secretary, Compliance Officer, Associate Vice President - Corporate Affairs and Legal
Dr. Prathap Chandra ReddyD
Non-Executive Non-Independent Vice Chairman of the Board
Dr. Sangita ReddyD
Non-Executive Non-Independent Director
Smt. Suneeta ReddyD
Non-Executive Non-Independent Director
Prof. Dr. Mahesh VermaD
Non-Executive Non-Independent Director
Mr. Tejpreet Singh ChopraD
Non-Executive Independent Director
Mrs. Madhumita GanguliD
Non-Executive Independent Director
View all
Incorporated on
16 Mar 1988
Last Annual
31 Mar 2026
Last Interim
30 Sep 2026
No. of Employees
3,000
IPO date
24 Feb 1997
Free Float
4,09,46,658
Website
Phone no.
+911129872126
Address
Sarita Vihar,, Delhi-Mathura Road, NEW DELHI, 110076, India
Corporate Actions
History of Indraprastha Medical Corporation Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Dividend₹ 4/share
Record date: 18th Sep 2026Ex-date: 18th Sep 2026
Announced on: 12th May 2026
Dividend₹ 4.50/share
Record date: 18th Sep 2025Ex-date: 18th Sep 2025
Announced on: 16th May 2025
Dividend₹ 4.50/share
Record date: 13th Sep 2024Ex-date: 13th Sep 2024
Announced on: 17th May 2024
Dividend₹ 3/share
Record date: 15th Sep 2023Ex-date: 15th Sep 2023
Announced on: 23rd May 2023
Dividend₹ 2.50/share
Record date: 16th Sep 2022Ex-date: 15th Sep 2022
Announced on: 20th May 2022
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Holdings and Presence
Indices and prominent investors with a stake in this stock.
Fundamental analysis overview of Indraprastha Medical Corporation Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
PE TTM of 17.24 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -69.06%
What is P/E Ratio?
Median: 55.72
Value 17.24
7.542061.01
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.04 as on 30 Sep 2026 and Debt to Equity decreased marginally by 0.01 in the last 1 year
What is Debt to Equity?
Consistently pays dividend
The company has not missed dividend payments once in the last 4 financial years
What is Dividend streak?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Analysts have been downgrading forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has decreased by -0.69% in the last 3 months, indicating weak earnings momentum
What is Earnings upgrade (3M)?
Moderate revenue growth but lower than median growth of industry
The company delivered moderate revenue growth of 10.72% for 12-month ended 30 Sep 2026 but the growth was 12.25 percentage points lower than median growth of industry
What is Sales growth (1Y)?
Median: 22.97
Value 10.72
-18.1340551.6
Low EPS growth and in line with median growth of industry
The company delivered low EPS growth of 9.91% for 12-month ended 30 Sep 2026 and the growth was 0.73 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Neutral
High ROE but declining trend
The company reported strong ROE of 26.09% for 12-month ended 30 Sep 2026 but ROE declined by -346 bps from 1 year ago
What is ROE (FY)?
Moderate and stable operating margin
The company reported moderate operating margin of 14.99% for 12-month ended 30 Sep 2026 and operating margin declined marginally by -30 bps from 1 year ago
What is Operating profit margin?
Company's earnings are of moderate quality
Earnings quality score of 54.8 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
54.8 / 100
Moderate dividend yield
The company has a moderate dividend yield of 1.11%